Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.

Minden MD, Hogge DE, Weir SJ, Kasper J, Webster DA, Patton L, Jitkova Y, Hurren R, Gronda M, Goard CA, Rajewski LG, Haslam JL, Heppert KE, Schorno K, Chang H, Brandwein JM, Gupta V, Schuh AC, Trudel S, Yee KW, Reed GA, Schimmer AD.

Am J Hematol. 2014 Apr;89(4):363-8. doi: 10.1002/ajh.23640. Epub 2014 Mar 3.

2.

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668.

Reid JM, Walden CA, Qin R, Ziegler KL, Haslam JL, Rajewski RA, Warndahl R, Fitting CL, Boring D, Szabo E, Crowell J, Perloff M, Jong L, Bauer BA, Mandrekar SJ, Ames MM, Limburg PJ; Cancer Prevention Network.

Cancer Prev Res (Phila). 2011 Mar;4(3):347-53. doi: 10.1158/1940-6207.CAPR-10-0313.

3.

Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys.

Kapetanovic IM, Muzzio M, Hu SC, Crowell JA, Rajewski RA, Haslam JL, Jong L, McCormick DL.

Cancer Chemother Pharmacol. 2010 May;65(6):1109-16. doi: 10.1007/s00280-009-1116-4. Epub 2009 Sep 16.

PMID:
19756605
4.
6.

Characterization of prednisolone in controlled porosity osmotic pump pellets using solid-state NMR spectroscopy.

Sotthivirat S, Lubach JW, Haslam JL, Munson EJ, Stella VJ.

J Pharm Sci. 2007 May;96(5):1008-17.

PMID:
17455361
7.

Evaluation of various properties of alternative salt forms of sulfobutylether-beta-cyclodextrin, (SBE)7M-beta-CD.

Sotthivirat S, Haslam JL, Stella VJ.

Int J Pharm. 2007 Feb 7;330(1-2):73-81. Epub 2006 Sep 16.

PMID:
17045435
9.

Stability of rifabutin in two extemporaneously compounded oral liquids.

Haslam JL, Egodage KL, Chen Y, Rajewski RA, Stella V.

Am J Health Syst Pharm. 1999 Feb 15;56(4):333-6.

PMID:
10690216
10.

The use of N,N-diethyl-m-toluamide to enhance dermal and transdermal delivery of drugs.

Windheuser JJ, Haslam JL, Caldwell L, Shaffer RD.

J Pharm Sci. 1982 Nov;71(11):1211-3.

PMID:
7175710
11.

GLC determination of whole blood antimalarial concentrations.

Nakagawa T, Higuchi T, Haslam JL, Shaffer RD, Mendenhall DW.

J Pharm Sci. 1979 Jun;68(6):718-21.

PMID:
458571
12.

A kinetic investigation of the interaction of serine transhydroxymethylase with glycine and serine.

Liu SH, Haslam JL.

Biochemistry. 1974 Jul 16;13(15):3079-85. No abstract available.

PMID:
4841056
13.

Immobilized enzyme electrode for the determination of arginase.

Booker HE, Haslam JL.

Anal Chem. 1974 Jul;46(8):1054-60. No abstract available.

PMID:
4852354
14.

Letter: Studies on histidinol dehydrogenase preliminary crystallographic data.

Yang HJ, Lee B, Haslam JL.

J Mol Biol. 1973 Dec 25;81(4):517-9. No abstract available.

PMID:
4591673
15.

A kinetic investigation of the interaction of serine transhydroxymethylase with glycine.

Cheng CF, Haslam JL.

Biochemistry. 1972 Sep 12;11(19):3512-8. No abstract available.

PMID:
5066198
16.

Calculation of rate constants from relaxation spectra of enzyme reactions.

Haslam JL.

J Phys Chem. 1972 Feb 3;76(3):366-9. No abstract available.

PMID:
5060755
17.

A kinetic investigation of the interaction of erythro-beta-hydroxyaspartic acid with aspartate aminotransferase.

Hammes GG, Haslam JL.

Biochemistry. 1969 Apr;8(4):1591-8. No abstract available.

PMID:
5805298
18.

A kinetic investigation of the interaction of alpha-methylaspartic acid with aspartate aminotransferase.

Hammes GG, Haslam JL.

Biochemistry. 1968 Apr;7(4):1519-25. No abstract available.

PMID:
5692575

Supplemental Content

Loading ...
Support Center